Search results
Found 22756 matches for
Oxford is at the forefront of teaching and research to help combat diseases affecting populations worldwide. Through its world-leading Centre for Tropical Medicine and Global Health (CTMGH), the University is working to find practical solutions to the problems these diseases cause. The centre conducts its research overseas in Africa and Asia, and across two sites in Oxford. The linked article shares three Oxford profiles.
‘Peer power’ transforming HIV testing among fishing communities in Uganda
9 February 2026
In Uganda’s fishing communities, Dr Joseph Matovu is leading a peer-led HIV self-testing project to overcome stigma and healthcare access barriers. With support from the Africa Oxford Initiative (AfOx), the PEST4MEN model empowers local leaders to distribute self-test kits, improving uptake, linkage to care, and community ownership of HIV prevention.
Professor Sir Nicholas White OBE KCMG FRS
3 February 2026
The Centre for Tropical Medicine and Global Health, the University of Oxford and the Nuffield Department of Medicine greatly mourn the death of Professor Sir Nicholas White, a distinguished clinician and scientist who was internationally recognised as the leading figure in improving the treatment of malaria worldwide, and whose work has made a lasting contribution to global health research - saving millions of lives worldwide. Our thoughts are with his family at this time.
OUCRU & the Hospital for Tropical Diseases: 35 years of partnership
2 February 2026
From our earliest malaria trials in 1991 to today’s shared work on many infectious diseases, OUCRU marks 35 years of partnership with the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam, advancing research that improves patient care and strengthens responses to infectious diseases. Rooted in frontline clinical collaboration, OUCRU continues to drive evidence-based innovations, build local research capacity, and address evolving health challenges across Vietnam and the region.
Back by popular demand: The AMR Circus!
30 January 2026
Following the success of the Antimicrobial Resistance (AMR) Circus in Cambodia during May 2025, the Phare Ponleu Selpak (Brightness of the Arts) School students were back with new performances in Jan 2026.
Deirdre Hollingsworth among the first Fellows of the Academy for the Mathematical Sciences
30 January 2026
Professor Deirdre Hollingsworth is among twelve Oxford academics appointed to the Academy for the Mathematical Sciences’ inaugural cohort of Fellows, which will bring together the UK’s strongest mathematicians across academia, education, business, industry, and government to help solve some of the UK’s biggest challenges.
AMR Kenya 2026 Conference: Working Together to Tackle Antimicrobial Resistance
30 January 2026
The AMR Kenya 2026 Conference convened stakeholders across sectors to address the growing threat of antimicrobial resistance (AMR) in Kenya and the region. Under the theme “Working Together to Tackle AMR in Kenya,” participants co-developed practical solutions, highlighting the need for robust systems, data, stewardship, and local leadership. Interactive sessions addressed diagnostics, One Health, vaccines, and infection control. The conference concluded with a call for African-led, locally grounded responses and sustained investment to protect antimicrobial effectiveness and public health.
New interactive tool to assess devices for detecting substandard medicines
23 January 2026
The Medicine Quality Research Group has launched DAFODIL, a new digital platform to help regulators assess portable devices for detecting substandard and falsified medicines. Poor-quality medicines, responsible for serious health risks, remain a major issue globally. DAFODIL compiles available scientific evidence to enable comparisons of medication screening devices, supporting informed decision-making. Developed with input from regulators and funded by the Gates Foundation, the tool aims to strengthen global medicine quality surveillance and response.
“AMR Ambassador” Competition: When Students Become Voices Against Antimicrobial Resistance
23 January 2026
The OUCRU Hanoi Research Team and the PCE team, in collaboration with the Students’ Clinical Pharmacy Club, Hanoi University of Pharmacy successfully conducted the AMR Ambassador Competition on Monday, 12 January 2026, at Kim Lien High School, Hanoi.
IHTM students debate at Oxford Union
15 January 2026
Putting months of debate training into practice
OUCRU’s LAST ACT trial explores personalised treatment for tuberculous meningitis
15 January 2026
OUCRU’s LAST ACT trial, published in Nature Medicine, is the first tuberculosis study to assess treatment based on host genetics. The trial tested whether dexamethasone could be withheld in patients with low- or medium-inflammatory LTA4H genotypes. Results showed no evidence that placebo was as effective as dexamethasone, which remained safe and modestly effective across genotypes. These findings support continued use of dexamethasone and highlight the need for better-targeted treatments for tuberculous meningitis.
Oxford licenses Rift Valley fever vaccine candidate amid West Africa outbreak
13 January 2026
The University of Oxford has licensed an investigational Rift Valley fever vaccine candidate to the Serum Institute of India (SII) as outbreaks of the disease continue in parts of West Africa. Professor George Warimwe leads the development of the ChAdOx1 RVF vaccine, now progressing from lab to field use. The initiative enables rapid vaccine production and testing, offering hope for controlling this neglected zoonotic disease.
New Beginnings
12 January 2026
A look back at first-term activities as Hilary Term begins for the 2025/26 IHTM cohort
Francois Nosten on Fever Pitch podcast, on a collapsing border where medicine meets war
6 January 2026
Professor Francois Nosten, Director of MORU's Shoklo Malaria Research Unit (SMRU), reflects on the decades he’s spent on the border between Thailand and Myanmar, a place of relentless upheaval and quiet endurance. From the 1980s onward, he has lived amid war, displacement, and disease, building a fragile bridge between science and survival. He characterizes the border as a wound that never quite closes – people cross not for opportunity but to escape a state that devours its own. What he describes is not steady progress but a cycle of collapse and recovery, every advance shadowed by the return of violence and the onset of disease.
Professor Nicholas Day Honoured for Services to Global Health
6 January 2026
Professor Nicholas Day has been appointed Companion of the Order of St Michael and St George (CMG) for his outstanding contributions to global health research in the Kings New Years Honours 2026. With a career spanning over three decades at OUCRU and MORU, his leadership in infectious disease research has significantly advanced health equity in low-resource settings.
SMRU’s ‘TB Village’: A lifeline for marginalised patients on the Thai–Myanmar border
6 January 2026
In a settlement of bamboo cabins, among mango and jackfruit trees, the Shoklo Malaria Research Unit runs a secluded clinic known as 'TB Village.' Reachable only by dirt roads, this sanctuary provides critical treatment and quarantine for dozens of marginalized Burmese tuberculosis patients. Here, at SMRU, patients receive care for diseases like tuberculosis and malaria. The unit works to heal patients and prevent outbreaks from crossing borders, providing a lifeline of safety.
Building Lasting Impact: Professor Guy Thwaites’ Legacy at OUCRU
1 January 2026
Over more than a decade of leadership, Professor Guy Thwaites helped steer the Oxford University Clinical Research Unit through a period of strategic growth and increasing global relevance. Under his direction, OUCRU strengthened its focus on research driven by clinical need, expanded its regional footprint, and deepened its contribution to tackling some of the most pressing infectious disease challenges in Southeast Asia and beyond.
GRAM to host 29th January webinar on AMR tools and resources
1 January 2026
The GRAM Project invites health professionals, researchers, and policymakers to a webinar on 29 January: “AMR Tools and Resources: An Introduction for Health Professionals and Researchers.” The 90-minute session will showcase key tools including IHME’s MICROBE platform, WHO’s GLASS system, the AMR R package, and the GRAM–IDDO AMR Data Repository. These open-access resources support evidence-based action on antimicrobial resistance, particularly in low- and middle-income countries. Two identical sessions are offered to accommodate global participation.
Oxford-led researchers develop a low-cost rapid test to identify heat-damaged vaccines
17 December 2025
Researchers from Medicine Quality Research Group, the University of Oxford and their collaborators have developed and evaluated a novel low-cost, rapid method to identify heat-exposed sucrose-containing vaccines without the need for sophisticated laboratory equipment.
Research Spotlight: The IRONMUM Trial at SMRU
16 December 2025
IRONMUM is one example of SMRU’s long-standing collaboration with global partners to address critical health challenges in low- and middle-income settings. Through partnerships with institutions such as the University of Oxford and the Mahidol Oxford Tropical Medicine Research Unit (MORU), SMRU conducts research that is firmly grounded in local realities, ensuring that preventive strategies and treatments are effective where they are needed most. Working on the Thailand–Myanmar border since 1986, SMRU combines research, clinical care, and humanitarian action to improve the health of mothers, children, and vulnerable populations affected by infectious diseases and limited access to healthcare.
International collaboration launches largest-ever therapeutics trial for patients hospitalised with dengue
16 December 2025
A landmark international research collaboration has launched the largest clinical trial ever conducted to test therapeutics for moderate-severe dengue, a mosquito-borne viral disease that continues to spread rapidly driven by climate change and globalisation.